feed,title,long_url,short_url
Investors,"Why Dyne Therapeutics, With A 108% Run This Year, Just Catapulted Again",https://www.investors.com/news/technology/biotech-stock-dyne-therapeutics-muscular-dystrophy/,https://da.gd/9l6hn
